Nadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study design

Thrombosis Journal

Volumn 2, Issue , 2004, Pages

  Gurfinkel, Enrique P ^a   Perel, Cecilia ^a   Pombo, Gonzalo ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; SODIUM CHLORIDE;

ABDOMINAL WALL; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG TARGETING; EXPERIMENTAL DESIGN; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; NONSURGICAL INVASIVE THERAPY;

EID: 4344702110     PISSN: 14779560     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-9560-2-6     Document Type: Article

References (15)

1. Landray MJ, Thambyrajah J, McGlynn FJ, Jones J, Baigent C, Kendall M, Townend JN, Eheeler DC: Epidemiological Evaluation of Known and Suspented Cardiovascular Risk Factors in Chronic Renal Impairment. Am J of Kidney Dis 2001, 38(3):537-46.
2. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfuy PF, Levy D: Cardiovascular Disease and Mortality in community-based cohort with mild renal insufficiency. Kidney Int 1999, 56:2214-9.
3. Mann JF, Gerstein HC, Pogue J, Bosch , Yusuf S: Renal Insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE Randomized Trial. Ann Intern Med 2001, 134:629-36.
4. Dries D, Exner D, Domansky M, Greenberb B, Stevenson L: The prognostic Implications of Renal Insufficiency in Asyntomatic and Symtomatic Patients with Left Ventricular Systolic Disfunction(SOLVD). JACC 2000, 35(3):681-9.
5. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC, Hamm CW, McFadden E, de Feyter PJ, Specchia G, Ruzyllo W: Management of acute coronary síndromes: acute coronary síndromes without persistent ST segment elevation. Recomendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000, 21:1406-1432.
6. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith 3rd EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith Jr SC: ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients UIT Unstable Angina). Circulation 2000, 102:1193-1209.
7. Cohen M, Gensini GF, Gurfinkel E, Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Krzeminska-Pakula M, Danchin N, White HD, Santopinto J, Bigonzi F, Hecquet C, Vittori L, TETAMI Investigators: The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial. J Am Coll Cardiol 2003, 42(8):1348-1356.
8. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E: Enoxaparin prevents death and cardiac ischemia event in unstable angina / non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial. Circulation 1999, 100:1593-1601.
9. Collet JP, Montalescot G, Choussat R, Lison L, Ankri A: Enoxaparin in unstable angina patients with renal failure. Int J Cardiol 2001, 80:81-82.
10. Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S: Unfractionated heparin and low molecular weight heparin in acute coronary síndrome without ST elevation: a meta-analysis. Lancet 2000, 355:1936-1942.
11. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serun creatinine. Nephron 1976, 16:31-41.
12. Sixth ACCP Consensus Conference on Antithrombotic Therapy Chest 2001, 119(suppl):S108-S121.
13. Fliser D, Bischoff I, Hanses A, Block S, Joest M, Ritz E, Block S, Joest M, Ritz E, Mutschler E: Renal handling of drugs in the healthy elderly. Eur J Clin Pharmacol 1999, 55:205-211.
14. Cerne D, Kaplan-Pavlovic S, Kranjek I, Jurgens G: Mildly elevated serum creatinine concentration correlates with the extent of coronary atherosclerosis. Ren Fail 2000, 22(6):799-808.
15. Levey A, Beto J, Coronado B, Eknoyan G, Foley R, Kasiske B, Klang M, Maillioux L, Manske C, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright Jr JT: National Kidney Foundation Task Force on Cardiovascular Disease. Am J of Kidney Dis 1998, 3 2:853-906.